Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events

INTRODUCTION: Long-chain omega-3 polyunsaturated fatty acids (OM3 PUFA) are commonly used for cardiovascular disease prevention. High-dose eicosapentaenoic acid (EPA) is reported to reduce major adverse cardiovascular events (MACE); however, a combined EPA and docosahexaenoic acid (DHA) supplementat...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Viet T., Knight, Stacey, Watrous, Jeramie D., Najhawan, Mahan, Dao, Khoi, McCubrey, Raymond O., Bair, Tami L., Horne, Benjamin D., May, Heidi T., Muhlestein, Joseph B., Nelson, John R., Carlquist, John F., Knowlton, Kirk U., Jain, Mohit, Anderson, Jeffrey L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482040/
https://www.ncbi.nlm.nih.gov/pubmed/37680562
http://dx.doi.org/10.3389/fcvm.2023.1229130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482040/
https://www.ncbi.nlm.nih.gov/pubmed/37680562
http://dx.doi.org/10.3389/fcvm.2023.1229130

Ejemplares similares